Lawsuit on Olanzapine and physical health conditions
People who took the drug Olanzapine, also called Zyprexa, on or before June 6, 2007 may have a claim in a lawsuit against the company that manufactures the drug.
A class action lawsuit was brought against Ely Lily on behalf of people who developed the following conditions during or after taking Zyprexa for at least 90 days: diabetes or hyperglycemia; worsening of existing diabetes; or diabetic ketoacidosis or pancreatitis. Any secondary problems associated with diabetes (e.g., stroke, heart attack, blindness, amputation, kidney failure, coma) are also important to the suit.
The Canadian class action has been settled, and courts in Ontario, B.C. and Québec approved the settlement on June 15, 2010. A free event to help people find out if they are eligible for money and how to start a claim is being held on September 23, 2010 at 1 p.m. at the Native Canadian Centre of Toronto, located at 16 Spadina Road, Toronto. The event is sponsored by Sound Times Support Services and CLASP (Osgoode Hall Legal Clinic).
The deadline for claims is October 28, 2010. For more information about the lawsuit and the Toronto event, visit www.soundtimes.com/zyprexaclassaction or contact Class Counsel (the lawyers who are handling the claims) at Stevensons LLP, 144 Front Street West, Suite 400, Toronto, M5J 2L7, or contact Daniel McConville at 1-866-940-8329 or email@example.com.